iShares MSCI New Zealand ETF
ENZL · ETF
About ENZL
- Issuer
- iShares
- Tracks
- MSCI New Zealand All Cap Top 25 Capped Index - Benchmark TR Net
- Expense ratio
- 0.5%
- Assets under management
- $65.99M
- Inception
- Sep 1, 2010
- Asset class
- Equity
- Website
- us.ishares.com
ENZL key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 8.96K
- Volume
- 1.06K
- Open price
- $45.17
- High today
- $45.16
- Low today
- $45.16
- 52 Week high
- $49.04
- 52 Week low
- $41.69
iShares MSCI New Zealand ETF (ENZL) at a glance
iShares MSCI New Zealand ETF (ENZL) last traded at $45.16, with a market cap of 0 and a price-to-earnings ratio of 0.00.
Volume so far is 1.06K shares, below the average of 8.96K shares a day.
Over the past year iShares MSCI New Zealand ETF has ranged from $41.69 to $49.04, and now sits 47% of the way up that range.
ENZL news
- Stjepan Kalinic
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.